[Torsade de pointes: a new way to kill drugs].

Suppr

超能文献

作者信息

Tamargo Menéndez L J

出版信息

An R Acad Nac Med (Madr). 1998;115(1):23-42; discussion 42-6.

PMID:9741134

Abstract

摘要

相似文献

[Torsade de pointes: a new way to kill drugs].

An R Acad Nac Med (Madr). 1998;115(1):23-42; discussion 42-6.

Diphenhydramine induced QT prolongation and torsade de pointes: An uncommon effect of a common drug.

Cardiol J. 2010;17(5):509-11.

Long QT syndrome caused by noncardiac drugs.

Prog Cardiovasc Dis. 2003 Mar-Apr;45(5):415-27. doi: 10.1053/pcad.2003.00101.

Torsade de pointes associated with rupatadine.

Rev Esp Cardiol. 2009 Mar;62(3):330-1; author reply 332. doi: 10.1016/s1885-5857(09)71568-3.

[Side effects, unwanted drug interactions and the problem of cardiotoxicity].

Przegl Lek. 2003;60(4):196-8.

The pause that refreshes, or does it? Mechanisms in torsades de pointes.

Heart. 2000 Sep;84(3):235-7. doi: 10.1136/heart.84.3.235.

Combined use of astemizole and ketoconazole resulting in torsade de pointes.

J Formos Med Assoc. 1997 Feb;96(2):144-6.

Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.

Drug Saf. 2002;25(4):263-86. doi: 10.2165/00002018-200225040-00004.

The QT interval and torsade de pointes.

Drug Saf. 1999;21 Suppl 1:5-10; discussion 81-7. doi: 10.2165/00002018-199921001-00002.

Assessing the cardiac safety of ebastine. Prologue.

Drug Saf. 1999;21 Suppl 1:1-3. doi: 10.2165/00002018-199921001-00001.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Torsade de pointes: a new way to kill drugs].

An R Acad Nac Med (Madr). 1998;115(1):23-42; discussion 42-6.

Diphenhydramine induced QT prolongation and torsade de pointes: An uncommon effect of a common drug.

Cardiol J. 2010;17(5):509-11.

Long QT syndrome caused by noncardiac drugs.

Prog Cardiovasc Dis. 2003 Mar-Apr;45(5):415-27. doi: 10.1053/pcad.2003.00101.

Torsade de pointes associated with rupatadine.

Rev Esp Cardiol. 2009 Mar;62(3):330-1; author reply 332. doi: 10.1016/s1885-5857(09)71568-3.

[Side effects, unwanted drug interactions and the problem of cardiotoxicity].

Przegl Lek. 2003;60(4):196-8.

The pause that refreshes, or does it? Mechanisms in torsades de pointes.

Heart. 2000 Sep;84(3):235-7. doi: 10.1136/heart.84.3.235.

Combined use of astemizole and ketoconazole resulting in torsade de pointes.

J Formos Med Assoc. 1997 Feb;96(2):144-6.

Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.

Drug Saf. 2002;25(4):263-86. doi: 10.2165/00002018-200225040-00004.

The QT interval and torsade de pointes.

Drug Saf. 1999;21 Suppl 1:5-10; discussion 81-7. doi: 10.2165/00002018-199921001-00002.

Assessing the cardiac safety of ebastine. Prologue.

Drug Saf. 1999;21 Suppl 1:1-3. doi: 10.2165/00002018-199921001-00001.